FDA Approved: VIGABATRIN — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Vigabatrin from Par Health USA, LLC, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Epilepsy
• Infantile Spasms

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)